Cyanotech goes condition-specific with new supplement blends
The line, which is designed to reinforce the benefits of its BioAstin astaxanthin ingredient, will be mainly sold as finished products. However, Cyanotech president and CEO Andrew Jacobson told NutraIngredients-USA.com that it could also work with other supplement manufacturers to provide them with custom formulations.
The line currently includes five products, which were developed by Robert Corish, MD, a founding member of the American Society of Integrative Medical Practitioners.
As well as Cyanotech’s BioAstin, the products include a variety of active ingredients shown to benefit the specific condition targeted, including joint, heart, skin and eye health.
Cyanotech said it will shortly also be launching a line of products made with its spirulina ingredient.
